AB Science receives Notice of Deficiency (NOD) from Health Canada for masitinib in the treatment of amyotrophic lateral sclerosis (...
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF DEFICIENCY (NOD) FROM HEALTH CANADA FOR MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AB SCIENCE HAS 90 CALENDAR DAYS TO RESPOND TO THE NOD Paris, December 13, 2022, 6pm CET AB Science SA ( …